Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: India Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20084
20103
20113
20121
20131
20181
20192
20202
20212
20225
20236
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting9
Terminated7
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
UCB Pharma4
Anthera Pharmaceuticals3
Bristol-Myers Squibb3
Eli Lilly and Company3
Amgen2
MedImmune LLC2
Viatris Innovation GmbH2
Alumis Inc1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic35
Autoimmune Diseases12
Connective Tissue Diseases7
Immune System Diseases7
Lupus Nephritis7
Nephritis2
Proteinuria1

Trials

Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.